PRLD

Question 1

Who is the CEO of Prelude Therapeutics Inc?

Accepted Answer

Dr. Krishna Vaddi is the Chief Executive Officer of Prelude Therapeutics Inc, joining the firm since 2016.

Question 2

What is the price performance of PRLD stock?

Accepted Answer

The current price of PRLD is $2.27, it has increased 0.44% in the last trading day.

Question 3

What are the primary business themes or industries for Prelude Therapeutics Inc?

Accepted Answer

Prelude Therapeutics Inc belongs to Biotechnology industry and the sector is Health Care

Question 4

What is Prelude Therapeutics Inc market cap?

Accepted Answer

Prelude Therapeutics Inc's current market cap is $142.7M

Question 5

Is Prelude Therapeutics Inc a buy, sell, or hold?

Accepted Answer

According to wall street analysts, 5 analysts have made analyst ratings for Prelude Therapeutics Inc, including 3 strong buy, 5 buy, 1 hold, 1 sell, and 3 strong sell

Prelude Therapeutics Inc (PRLD) Price

PRLD Stock Price Chart

Follow-Up Questions

Who is the CEO of Prelude Therapeutics Inc?

What is the price performance of PRLD stock?

What are the primary business themes or industries for Prelude Therapeutics Inc?

What is Prelude Therapeutics Inc market cap?

Is Prelude Therapeutics Inc a buy, sell, or hold?

Follow-Up Questions

Who is the CEO of Prelude Therapeutics Inc?

What is the price performance of PRLD stock?

What are the primary business themes or industries for Prelude Therapeutics Inc?

What is Prelude Therapeutics Inc market cap?

Is Prelude Therapeutics Inc a buy, sell, or hold?